| Yang, Jianjun |
NCT04713358: Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia |
|
|
| Recruiting | 4 | 520 | RoW | Nalmefene, normal Saline | RenJi Hospital, Shanghai Tong Ren Hospital, First Affiliated Hospital of Guangxi Medical University, The First Affiliated Hospital of Zhengzhou University | Resuscitation | 12/23 | 12/23 | | |
NCT06192186: Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma |
|
|
| Recruiting | 4 | 110 | RoW | Adebrelimab combined with SOX regimen, Placebo combined with SOX (S-1/oxaliplatin) regimen | Yang Jianjun, PhD | Locally Advanced Gastric Adenocarcinoma | 12/25 | 12/25 | | |
RNPLS-01, NCT06169410: Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer |
|
|
| Recruiting | 4 | 140 | RoW | nab-paclitaxel, lobaplatin, and S-1 combined with ramucirumab, nab-paclitaxel, lobaplatin, and S-1 | Yang Jianjun, PhD | Advanced Gastric Cancer | 12/25 | 12/25 | | |
NCT06550453: Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer |
|
|
| Recruiting | 4 | 20 | RoW | Pabolizumab+ bevacizumab and CapeOX (bevacizumab + oxaliplatin + capecitabine) | yangjianjun | Locally Advanced Colorectal Cancer | 01/25 | 01/26 | | |
NCT06332716: Research on the Correlation Between Organoid Drug Sensitivity Testing and Precise Treatment of Gastrointestinal Tumors |
|
|
| Recruiting | 3 | 68 | RoW | Based on diagnostic and treatment guidelines/expert consensus, as well as clinical treatment experience, it is recommended that no more than 9 drugs be used for drug sensitivity testing each time. | Jianjun Yang,MD | Gastrointestinal Tumors，3D Organoids，Drug Sensitivity | 12/25 | 12/25 | | |
NCT05545137: Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection |
|
|
| Completed | 3 | 299 | RoW | Pivmecillinam hydrochloride tablets, Selexid®, Fosfomycin Tromethamine Granules, Monurol® | Benova (Tianjin) Innovative medicine Research Co., Ltd. | Uncomplicated Urinary Tract Infection | 02/24 | 02/24 | | |
NCT05052931: Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer |
|
|
| Recruiting | 2 | 10 | RoW | Nab-paclitaxel combined with oxaliplatin and S-1 | Jianjun Yang, CSPC Ouyi Pharmaceutical Co., Ltd. | Gastric Cancer | 12/23 | 12/23 | | |
NCT05544812: A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer |
|
|
| Recruiting | N/A | 10 | RoW | Sintilimab ，bevcizumab/cetuximab，XELOX | Xijing Hospital | Colorectal Cancer | 09/22 | 06/23 | | |
NCT05065515: Establishment of Individualized Immunotherapy Strategy and Platform Based on Changes of Intestinal Microbiota |
|
|
| Recruiting | N/A | 40 | RoW | | Xijing Hospital | Gut Microbiota | 10/23 | 12/23 | | |
NCT05050760: DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer |
|
|
| Recruiting | N/A | 55 | RoW | Camrelizumab, DCF | Xijing Hospital | ESCC | 12/23 | 12/23 | | |
NCT06367205: Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations |
|
|
| Recruiting | N/A | 380 | RoW | Goal-Directed Fluid Therapy (GDFT), GDFT, Regular Fluid Therapy | RenJi Hospital | Delayed Graft Function, End Stage Renal Disease, Kidney Transplantation | 04/26 | 06/26 | | |
NCT06030804: Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery |
|
|
| Recruiting | N/A | 4532 | RoW | Dexmedetomidine, Dexmedetomidine hydrochloride, Placebo, Normal saline | Peking University First Hospital, Peking University | Elderly, Cancer Surgery, Dexmedetomidine, Long-Term Survivors | 09/25 | 10/28 | | |
